SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?
finance.yahoo.com
29.08.2026 00:26
1 views
Copy link
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
1 outlet
Could Ionis Pharmaceuticals (IONS) Stock Become a Biotech Powerhouse as its Commercial Pipeline Takes Off?
finance.yahoo.com
29.08.2026
Related stories
Trump’s ‘economic D-day’ against Iran risks driving the stakes even higher | Sina Toossi
theguardian.com · 30.08
New payment set up? Get in touch! The bank scam where your ‘bank’ is the scammer
theguardian.com · 30.08
On long road back from Brexit, north-east’s recovery rides on survival of Nissan’s ‘shining star’ plant
theguardian.com · 30.08
‘You’re at war when you get attacked’: Mark Carney shows combative nature in face-off with Trump
theguardian.com · 30.08
What’s the fiscal hit from higher yields?
ft.com · 30.08
Incoming Swiss banking chief warns against regulatory over-reach
ft.com · 30.08